Not exact matches
Although Lundblad expects a lot
from her group, she's evenhanded and willing to give people a chance to prove themselves, according to
pediatric oncologist Alison Bertuch.
As a new generation of gene therapy clinical trials shows promise to cure or halt the progression of several rare diseases, the time has come to explore ways to pay for the cutting edge treatments, a
pediatric hematologist -
oncologist from Dana - Farber / Boston Children's Cancer and Blood Disorders Center argues in a commentary published by the journal Science.
All four boys are alive and have improved between nine and 24 months following treatment, according to study principal investigator Sung - Yun Pai, MD, a
pediatric hematologist -
oncologist from Dana - Farber / Boston Children's Cancer and Blood Disorders Center.